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Abstract: The neglected tropical diseases (NTDs) repre-
sent some of the most common infections of the poorest
people living in the Latin American and Caribbean region
(LAC). Because they primarily afflict the disenfranchised
poor as well as selected indigenous populations and
people of African descent, the NTDs in LAC are largely
forgotten diseases even though their collective disease
burden may exceed better known conditions such as of
HIV/AIDS, tuberculosis, or malaria. Based on their preva-
lence and healthy life years lost from disability, hookworm
infection, other soil-transmitted helminth infections, and
Chagas disease are the most important NTDs in LAC,
followed by dengue, schistosomiasis, leishmaniasis, tra-
choma, leprosy, and lymphatic filariasis. On the other
hand, for some important NTDs, such as leptospirosis and
cysticercosis, complete disease burden estimates are not
available. The NTDs in LAC geographically concentrate in
11 different sub-regions, each with a distinctive human
and environmental ecology. In the coming years, schisto-
somiasis could be eliminated in the Caribbean and
transmission of lymphatic filariasis and onchocerciasis
could be eliminated in Latin America. However, the
highest disease burden NTDs, such as Chagas disease,
soil-transmitted helminth infections, and hookworm and
schistosomiasis co-infections, may first require scale-up of
existing resources or the development of new control
tools in order to achieve control or elimination. Ultimately,
the roadmap for the control and elimination of the more
widespread NTDs will require an inter-sectoral approach
that bridges public health, social services, and environ-
mental interventions.
The Neglected Tropical Diseases in the Latin
American and the Caribbean Region
The neglected tropical diseases (NTDs), a group of chronic,
debilitating, and poverty-promoting parasitic, bacterial, and some
viral and fungal infections, are among the most common causes of
illness of the poorest people living in developing countries [1]. Their
control and elimination is now recognized as a priority for achieving
United Nations Millennium Development Goals (MDGs) and
targets for sustainable poverty reduction [1–3]. Approximately
40% of the estimated 556 million people living in the Latin
American and the Caribbean region (LAC) live below the poverty
line, including 47 million people who live on less than US$1 per day,
and another 74 million people who live on less than US$2 per day
[4,5]. Relative to sub-Saharan Africa and Asia, where NTDs also
occur, the character of poverty inLAC is unique. In terms of income
distribution, LAC exhibits the highest inequality anywhere [6], with
the richest one-tenth of the population earning 48% of total income
and the poorest tenth earning only 1.6% [7]. Of LAC’s estimated
213 million impoverished people, approximately one-third live in
rural poverty as subsistence farmers, ranchers, and fishermen [8],
typically in communities of indigenous and African descent where
they face a high level of social exclusion and social inequity [9],
includinglackofaccesstosafewaterandhealthcareservices[10,11].
Two-thirds of the region’s poor live in favelas, asentamientos pobres,
barrios pobres, turgurias,a n da ´reas perife ´ricas, i.e., urban and peri-urban
communities where poverty combines with the conditions of unsafe
water, poor sanitation, and the proliferation of rodent animal
reservoirs and vectors [8,12].
Poverty is not the only major determinant for risk of acquiring
NTDs in LAC. Instead, it combines with other inequities related
to ethnicity (e.g., indigenous groups and people of African
descent), age and gender (i.e., children and women), and a
patchwork of unique ecological niches to establish sometimes
highly focal epidemiological NTD ‘‘hot spots.’’ This has important
implications for the control of NTDs in LAC, which may differ
from the integrated NTD control currently being advocated for
and tested in sub-Saharan Africa and elsewhere [1]. Here, we
focus on some of the unique aspects of NTD disease burden and
endemicity in the LAC region, as well as the prospects for NTD
control and elimination in the region. The review of the literature
was conducted using the online database PubMed from 2000 to
2007 with United States National Library of Medicine Medical
Subject Headings, the specific diseases listed as neglected tropical
diseases on the PLoS Neglected Tropical Diseases Web site (http://
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LAC. Reference lists of identified articles and reviews were also
hand searched as were databases from the Pan American Health
Organization (PAHO) Web site (http://www.paho.org).
Burden and Geographic Distribution of Disease
The NTDs in LAC may be characterized by two major patterns
of disease distribution. The first is a pattern of widespread
endemicity such as that seen for the soil-transmitted helminth
(STH) infections, Chagas disease, and dengue; the second pattern
is one of geographically restricted endemicity as the result of
concerted public health interventions and ecological conditions as
seen for onchocerciasis, lymphatic filariasis (LF), and schistosomi-
asis in areas such as the Caribbean and Guyana shield. The latter
group may represent a distinct situation from other parts of the
world, as they may be said to represent a ‘‘last stronghold’’ of
endemic focal communicable diseases, that can be eliminated in a
region but are not yet. In this sense, the presence of such NTDs
represents a moral burden as well as an epidemiological burden.
Because they are seen by some as illustrations of the failure of
primary health care implementation [13], the NTDs also represent
a moral imperative for action to complete primary health care
implementation where it has failed and make it accessible to all.
Ault [8] previously listed the major NTDs in LAC, and Table 1
ranks these NTDs by their estimated prevalence, at-risk popula-
tion, and distribution, while Tables 2 and 3 rank the NTDs by
their estimated disease burdens measured in disability-adjusted life
years (DALYs). The major STH infections are the most prevalent
NTDs, and the STH infections and Chagas disease are responsible
for the highest estimated NTD burden in LAC. They are followed
by dengue, schistosomiasis, leishmaniasis, and other NTDs.
However, dengue is considered underreported in the LAC region
[14], and because leishmaniasis frequently occurs in remote areas
or regions of guerilla conflict [15], its disease burden is not well
established except in some areas of Brazil, Peru, and Bolivia [16].
Based on global disease burden estimates in DALYs published
previously by the World Health Organization (WHO) and other
investigators [17,18], a range of estimates for NTDs in LAC is
provided in Table 2. Such DALY estimates were obtained by
adjusting the global estimates according to the percentage of the
disease burden determined to occur in LAC, or in some cases they
were quoted directly from WHO estimates (Table 2). From this
analysis it was determined that the total burden of these NTDs in
LAC may exceed the disease burdens from malaria or tubercu-
losis, and according to some estimates, the regional NTD disease
burden exceeds that of HIV/AIDS (Table 2). There are also a
number of other important NTDs in LAC (many of which are
zoonoses) for which the disease burdens as expressed in DALYs
have not been determined or reported (Table 3).
Helminth infections. The major helminth infections in LAC
include Necator americanus hookworm infection and other STH
infections, schistosomiasis, LF, cysticercosis, and onchocerciasis.
Trichuriasis (100 million cases) and ascariasis (84 million cases) are
the most prevalent NTDs and widely distributed throughout LAC
[19] (Table 1), with the largest estimated number of cases in Brazil,
Mexico, and Guatemala (Table 4). Guatemala exhibits the highest
prevalence of trichuriasis and ascariasis [19], which may partly
explain why this nation has the highest prevalence of underweight
children [20]; high rates of these two infections also occur along
the north Pacific coast of South America, where they are
associated with growth stunting [21], as well as in other parts of
Central America and the Caribbean [19]. By some estimates,
hookworm is the single leading cause of disease burden among the
NTDs (Table 2). Of the 50 million cases of hookworm infection
that occur in poor rural areas, approximately 65% occur in Brazil
(Table 4) [19]. In some regions of Minas Gerais State, Brazil, an
estimated 68% of the rural population is infected with hookworm
[22], where it is a major cause of anemia in children [23]. High
rates of infection also occur in neighboring Paraguay and Peru
[19,21,24,25], as well as in parts of Central America and in
Suriname [19]. Hookworm is also a major cause of adverse
pregnancy outcomes in LAC [25]. Two other STH infections,
toxocariasis [26,27] and strongyloidiasis [28,29], are also endemic
in LAC, but there are no estimates of their regional prevalence.
In 2000, Chitsulo et al. [30] determined that almost all of the
estimated 7.3 million cases of schistosomiasis in LAC, caused
exclusively by Schistosoma mansoni, occur in Brazil. More recently,
Steinmann et al. [31] estimated that there are currently only 1.8
million cases in LAC, with 84% of the cases in Brazil (Table 4).
The largest number of cases occurs in the eastern Brazilian states
of Minas Gerais and Bahia, as well as in the small neighboring
northeastern states of Sergipe, Alagoas, Pernambuco, and Paraiba
[32]. In Brazil, there is a high degree of N. americanus and S. mansoni
co-infection [22]. Outside of Brazil, S. mansoni infection occurs in
the Caribbean, especially in the Dominican Republic and in
Venezuela and Suriname [31].
Currently, four countries—Brazil, Dominican Republic,
Guyana, and Haiti—report active transmission of LF and are
actively conducting control or elimination efforts through mass
drug administration (MDA) [33]. Almost 80% of the LF cases
occur in Haiti, where more than 70% of that nation’s population is
also at risk for infection [20,33]. In Brazil, LF occurs primarily in
the metropolitan areas of Recife (Pernambuco State) and Maceio
(Alogoas State) [33]. Through MDA, campaigns to eliminate LF
(2.4 million people were treated in 2007) in the Caribbean are in
progress [33,34]. Onchocerciasis is currently endemic in six
countries, Brazil, Colombia, Ecuador, Guatemala, Mexico, and
Venezuela [35]. Through the Onchocerciasis Elimination Pro-
gram for the Americas (OEPA), more than 85% of eligible
populations in 13 endemic foci have been receiving ivermectin
MDA [35]. Foci in Guatemala, southern Mexico, and Venezuela
have the highest percentage of the population needing MDA [35].
OEPA has now come close to ending onchocerciasis ocular
morbidity in the Americas [35], and has established guidelines in
coordination with the WHO for the certification of onchocerciasis
elimination [36]. Transmission has been declared interrupted in
two foci since 2007, one in Colombia and one in Guatemala.
The major platyhelminth infections in LAC are three zoonoses:
cysticercosis, fascioliasis, and paragonimiasis. There are an
estimated 400,000 people with symptomatic cysticercosis in LAC
[37]. The infection may be eliminatable through better pig
husbandry and/or MDA of pigs and humans [37]. Human
fascioliasis is an important sheep-associated zoonosis in the Chaco
of Bolivia, Paraguay, and Argentina, in the Andean highland
region (the Altiplano [38,39]), and in parts of the Caribbean,
including Cuba, Dominican Republic, and Haiti [40,41].
Paragonimiasis has been reported from Colombia, Ecuador, and
Mexico [42], while echinococcosis is another major zoonosis in
areas dependent on sheep and other livestock [20].
Protozoan infections. Chagas disease is one of the highest
disease burden NTDs in LAC [43–50]. Almost all of the 8–9
million cases of Chagas disease [43,44] (with approximately
50,000 new cases annually [44]) occur in poor rural and,
increasingly, many new urban and peri-urban areas of Latin
America (Table 1). It is estitamed that up to 5.4 million people will
develop chronic Chagas heart disease [20,45], while 900,000 will
develop megaesophagus and megacolon [20]. In LAC, the burden
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www.plosntds.org 3 September 2008 | Volume 2 | Issue 9 | e300of disease caused by Trypanosoma cruzi infection is between five and
ten times greater than malaria [46]. Moreover, its economic
impact represents a significant percentage of the external debt of
the region [46]. Because of the propensity of the kissing bug vector
(especially Triatoma infestans) to live in the cracks and crevices and
roofs of poor-quality dwellings, and the lack of essential medicines
for patients during the acute stages of infection, Chagas disease is
disproportionately represented among people living in poverty
[12,46]. Despite successful elimination efforts in the southern cone
of South America [50] (for reasons discussed below), the disease
remains endemic in many regions of Central and South America
[48,49]. Chagas disease has also emerged or re-emerged in areas
of conflict, including Chiapas State, Mexico [47], and Colombia
[15]. Increasingly, dogs are recognized as important animal
reservoirs of the infection [48]. The major approaches to control
include improved case management and vector control programs,
together with housing improvement through regional programs,
which have been reviewed previously [20,48–50].
In LAC, both cutaneous and visceral forms of leishmaniasis result
primarily from zoonotic transmission from either canine or sylvatic
(e.g., opossum, sloth, anteater) reservoir hosts. The most important
determinants for the emergence of both new world zoonotic
cutaneous leishmaniasis (ZCL) and zoonotic visceral leishmaniasis
(ZVL) include poverty, urbanization, and human migration [16].
Leishmania mexicana, L. amazonensis, L. braziliensis, Lp a n a m e n s i s , L.
peruviana,a n dL. guyanensis are the major species that cause new world
ZCL [51]. Approximately 62,000 cases of ZCL occur primarily in
Brazil, Colombia, Paraguay, Venezuela, Panama, Ecuador, and
Peru [52] (Table 5), where urbanization near Lutzomyia sandfly
breeding sites has led to an increase in the number of cases [53]. In
addition, the emergence of ZCL in Colombia is linked to several
decades of armed and guerilla internal conflict fueled by cocaine
production and trafficking [15]. In northeastern Brazil, ZVL (L.
chagasi) has become an important infection in the favelas of Forteleza,
Salvador do Bahia, and other urban centers, including Rio de
Janeiro and Belo Horizonte [53]. In these impoverished urban and
peri-urban settings, the cracked walls and damp earth floors,
together with an absence of sanitation and inadequate garbage
collection, combine to create sandfly breeding sites [16]. With the
exception of Brazil, surveillance systems in Latin America have been
limited in their capacity to assess the true burden of ZVL. A regional
leishmaniasis control action plan is now being implemented [20].
Bacterial and fungal infections. The most important
bacterial NTDs are trachoma, leprosy, and some of the bacterial
Table 3. Major NTDs with No National or Regional Disease Burden Estimates in DALYs.
Helminth Infections Protozoan Infections Bacterial Infections
Fungal Infections and
Ectoparasitic Infections Viral Infections
Echinococcosis Amebiasis Bartonellosis Mycetomas Hemorrhagic fevers
Cysticercosis Giardiasis Buruli ulcer Paracoccidioidomycosis Rabies
Fascioliasis Leptospirosis Myiasis
Strongyloidiasis Plague Scabies
Toxocariasis Treponematoses (non-venereal) Tungiasis
doi:10.1371/journal.pntd.0000300.t003
Table 2. Ranking of NTDs by Disease Burden (DALYs) and Comparison with HIV/AIDS, Tuberculosis, and Malaria.
Disease
Estimated Global
Disease Burden in
DALYs
Number of Cases in LAC
(Number of Cases
Worldwide)
Estimated Percentage
of Disease Burden in
LAC
Estimated LAC Disease
Burden in DALYs Reference
Hookworm infection 1.5–22.1 million 50 million (576 million) 8.7% 130,500–1,923,000 [17,75]
Ascariasis 1.2–10.5 million 84 million (807 million) 10.4% 124,800–1,092,000 [17,75]
Trichuriasis 1.6–6.4 million 100 million (604 million) 16.6% 265,600–1.062,000 [17,75]
Chagas disease 0.667 million ND 99.8% 662,000 [18]
Dengue and DHF 0.6 million ND 11.2% 69,000 [18]
Leishmaniasis 2.1 million ND 2.1% 44,000 [18]
Schistosomiasis 4.5 million 1.8 million (207 million) 0.8% 36,000 [17,31]
Lymphatic Filariasis 5.8 million 0.72 million (120 million) 0.6% 34,800 [18,33]
Trachoma 2.3 million 1.1 million (84 million) 1.3% 23,200 [18,54]
Leprosy 0.2 million ND 9.0% 18,000 [18]
Total NTDs 56.6 million 8.8% 1,407,900–4,964,000
HIV/AIDS 84.5 million 3.8% 3,211,000 [18]
Tuberculosis 34.7 million 2.7% 928,000 [18]
Malaria 46.5 million 0.2% 111,000 [18]
DALYs for each disease in LAC were calculated using global burden data in [17] and [18] and followed by a determination of the percentage of the disease burden in
LAC based on the estimated number of cases in LAC (Table 1) divided by the estimated number of cases worldwide [1] multiplied by 100. Alternatively, for Chagas
disease, dengue and dengue hemorrhagic fever (DHF), leishmaniasis, and leprosy, information from the disease burdens quoted in [18] were used.
doi:10.1371/journal.pntd.0000300.t002
www.plosntds.org 4 September 2008 | Volume 2 | Issue 9 | e300zoonoses, especially leptospirosis. There are approximately 1
million cases of trachoma (ocular Chlamydia trachomitis infection) in
Latin America (Table 1), with 97% of the cases in Brazil and the
remainder in Guatemala and Mexico [54] (Table 6). Although
overall trachoma is not considered a major cause of blindness in
LAC [20], the Amazonian region is severely affected, and some
indigenous school-aged populations exhibit prevalence as high as
42% [55]. A federal school-based program for the control and
antibiotic treatment of trachoma is underway in Brazil. In Central
America, trachoma is endemic in focal areas of Guatemala [55],
while in Chiapas State, Mexico, the disease is on the verge of
elimination [20]. A total of 64,715 cases of leprosy (Mycobacterium
leprae) were in treatment in LAC with multi-drug therapy in 2006,
with 47,612 new cases detected (Table 1) [56]. Brazil has the
largest leprosy disease burden in LAC with 93% of the new cases,
and it is the only LAC country that has not yet achieved a goal to
Table 5. Geographic Distribution and Estimated Burden of Cutaneous Leishmaniasis and Visceral Leishmaniasis in LAC.
Disease Total Number of Cases Cases by Country Reference
Brazil Colombia Peru Nicaragua Bolivia
Leishmaniasis 62,000 CL 28,375 CL 22,000 CL (2005) 7,127 CL (2005) 3,312 CL (2005) 2,800 CL (2004) [20,52]
5,000 VL 3,386 VL (2004)
Some estimates are from 2004, others from 2005.
CL, cutaneous leishmaniasis; VL, visceral leishmaniasis.
doi:10.1371/journal.pntd.0000300.t005
Table 4. Geographic Distribution and Estimated Burden of the Major Helminthiases in LAC.
Disease Total Number of Cases
Country (Greatest
Number of Cases)
Country (2nd
Greatest Number
of Cases)
Country (3rd
Greatest Number
of Cases)
Country (4th and
5th Greatest
Number of Cases) Reference
Trichuriasis 100 million Brazil Mexico Colombia Guatemala [19]
18.9 million 18.3 million 15.4 million 8.6 million
Venezuela
8.7 million
Ascariasis 84 million Brazil Mexico Guatemala Argentina [19]
41.7 million 9.3 million 7.9 million 7.7 million
Hookworm 50 million Brazil Paraguay Guatemala Colombia [19]
32.3 million 3.2 million 3.0 million 3.0 million
Schistosomiasis 1.8 million Brazil Dominican Republic Venezuela Guadeloupe [31]
1.5 million 258,000 23,674 4,400
Suriname
3,935
Lymphatic filariasis 0.72 million Haiti Brazil Dominican Republic Guyana [20,33]
560,000 60,000 50,000 50,000
8.9 million at risk 6.0 million at risk 1.5 million at risk 0.74 million at risk 0.63 million at risk
Onchocerciasis 0.52 million at risk Guatemala Mexico Venezuela Ecuador [20,35,36]
0.20 million at risk 0.17 million at risk 0.11 million at risk 0.02 million at risk
doi:10.1371/journal.pntd.0000300.t004
Table 6. Geographic Distribution and Estimated Burden of the Bacterial NTDs in LAC.
Disease Total Number of Cases Cases by Country Reference
Blinding trachoma 1.1 million cases (2003) Brazil Guatemala Mexico [54]
a
1,064,218 (2003) 2,073 (2003) 290 (2003)
Leprosy 47,612 new cases (2006) Brazil Venezuela Paraguay Colombia [56]
44,436 (2006) 768 (2006) 404 (2006) 398 (2006)
aThe number of cases of trachoma in the LAC region was determined by querying the WHO global health atlas, selecting the terms noncommunicable diseases,
blindness, trachoma, active trachoma (TF/TI), all ages, year, applied time period: 2003. The number of cases reported included 1,064,218 in Brazil, 2,073 in Guatemala,
and 290 in Mexico.
doi:10.1371/journal.pntd.0000300.t006
www.plosntds.org 5 September 2008 | Volume 2 | Issue 9 | e300eliminate leprosy below the target of one case per 10,000
population [20]. Most of the cases of human brucellosis go
undiagnosed or unreported in LAC, while bovine tuberculosis has
been eliminated in many regions [20]. Leptospirosis is also an
important cause of morbidity in LAC, especially in the favelas of
Brazil and other urban slums [10,57,58], where it has been linked
to a very serious pulmonary hemorrhage syndrome [58].
Bartonellosis remains an important local sandfly-transmitted
bacterial infection in the Andean region [59], while cases of
Buruli ulcer are reported occasionally in LAC. Several mycoses,
such as paracoccidioidomycosis and mycetoma, are responsible for
major public health and economic hardships in Latin America;
these tend to concentrate around humid forests in subtropical and
tropical areas [60,61].
Viral infections. The most important viral NTDs are dengue
and yellow fevers. In 2006, more than one-half million cases of
dengue fever (’’classic dengue’’) (Table 1) were reported, as well as
14,459 cases of dengue hemorrhagic fever (DHF) [62]. Brazil
recorded the highest number of cases with 63% of LAC’s dengue
disease burden (Table 7); however, based on seroprevalence
studies, it is believed that the number of reported cases represents
only a fraction of the total number [14]. Dengue incidence is on
the rise as a consequence of an increasing distribution of the vector
Aedes aegypti (as well as a second vector, A. albopictus) as a result of
urbanization, increased human migrations and air travel, flooding
from global warming, and serious public health lapses in effective
vector containment [14]. The increase in cases has been
particularly striking during the 1990s and shortly after 2000,
when at least 25 countries reported either epidemics or sporadic
cases of DHF [14]. American dengue and DHF have a number of
unique features compared to dengue in Asia, including its
predilection to strike adults and children, its impact on the
elderly, and several unusual clinical sequelae, including shock in
the absence of hemorrhagic complications [14]. The economic
impact of dengue may run into the hundreds of millions of dollars
[14]. Through DENGUE-NET, a regional program for
epidemiological surveillance coordinated by PAHO and the
LAC ministries of health, efforts are in place to improve the
reporting of statistical data [20]. Important jungle yellow fever
outbreaks have been reported recently, with most of the cases in
Peru in 2006 [63], in Brazil in 2007–2008, and in Paraguay and
Argentina in 2008 [64,65]. The observation of apparent urban
transmission by A. aegypti in Paraguay in early 2008 would
represent the first urban transmission seen in five decades in LAC.
As a result, these countries have stepped up community and
traveler vaccination campaigns and vector control and
implemented a syndromic surveillance system [63], while since
2000, Peru, Bolivia, Paraguay, Colombia, Venezuela, Guyana,
and Trinidad and Tobago have incorporated yellow fever vaccine
into national child immunization schemes, seeking coverage rates
comparable to their current measles vaccination rates [63]. The
number of cases of rabies transmitted by dogs to humans continues
to decline in LAC, with the majority now being reported from low-
income groups living in urban slums of large cities in Bolivia,
Brazil, El Salvador, and Haiti [20].
The NTD-Vulnerable Populations: Peoples of
Indigenous and African Descent
The NTDs in the Americas are concentrated not only within
pockets of intense poverty, but also among selected vulnerable
populations, especially some indigenous populations and communi-
ties of African descent. In LAC, it is estimated that 7% of the total
population and 40% of the rural population belong to a unique
ethnic group [20]. Rural poverty disproportionately affects indige-
nouspeople,particularlyinBolivia,Colombia,Ecuador,Guatemala,
Mexico, and Peru, where 80% of these populations live [9]. In
Guatemala and in the neighboring states of southern Mexico, the
indigenous populations suffer from some of the highest rates of STH
infection in the Americas [19], as well high rates of onchocerciasis
[35] and Chagas disease [48]. Some of the indigenous populations
acquire their infections in agricultural labor camps and on
plantations [9,66]. Similarly, the indigenous people of Bolivia and
Peru experience high rates of fascioliasis, cysticercosis, and plague
[20,39,67,68]; those in Colombia are at risk for leishmaniasis,
Chagasdisease,and yellow fever[15];andinBrazil,thereareseveral
well-documented examples of high levels of STH infection and
subsequent growth stunting among indigenous people [69–72], as
wellastrachoma[55].Indigenouspeople alsooften bearthe brunt of
vector-borne NTDs that emerge during conflict [15,48]. In addition
to LAC’s indigenous communities, poor populations in communities
of African descent, such as those found in parts of the Caribbean,
Central America, and Brazil, suffer from high prevalence rates of
NTDs, especially N. americanus hookworm infection, LF, onchocer-
ciasis, and schistosomiasis. These infections were introduced into the
region during the Middle Passage, so that their prevalence among
the poor represents a tragic living legacy of the Atlantic slave trade
[73].
Past Successes and Current Challenges
There have been some extraordinary successes in both national
and regional efforts to take measures for controlling several of the
most important NTDs in LAC. First among them has been great
progress towards the elimination of LF and onchocerciasis. With
respect to the former, Brazil has reduced LF transmission from 11
known foci to one to two small areas, and the at-risk populations in
the Caribbean region, particularly in Haiti and Dominican
Republic, are receiving MDA [20,33,34]. Similarly, all six
onchocerciasis-endemic countries have met their full treatment
goals and no new ocular disease has been found in recent years;
MDA with ivermectin continues in the foci with active
transmission [35,36]. In addition, the prevalence of both trachoma
and leprosy has been declining in the region in recent decades [20]
and there is optimism that these two ancient scourges could be
eliminated in the coming decade. In the Caribbean, the incidence
of schistosomiasis has been dramatically reduced [31,32] and the
Table 7. Geographic Distribution and Estimated Burden of Reported Dengue Cases in LAC in 2006.
Disease
Total Number of
Reported Cases Reported Cases by Country Reference
Brazil Venezuela Colombia Mexico
Dengue 552,141 346,471 39,860 36,471 27,287 [62]
doi:10.1371/journal.pntd.0000300.t007
www.plosntds.org 6 September 2008 | Volume 2 | Issue 9 | e300disease seems potentially eliminatable. Through expanded use of
insecticides, improved housing, and other interventions, great
gains have been made by Iniciativa de Salud del Cono Sur
(INCOSUR) in their efforts to eliminate Chagas disease from
South America’s southern cone [50]. An exciting new effort to
eliminate Chagas disease throughout the region by 2010 has been
launched through a new Global Network for Chagas Elimination
[43]. Some countries, including Argentina, Belize, Ecuador, Haiti,
Honduras, and Nicaragua, have recently initiated major expan-
sions of their STH control programs.
At the same time, enormous challenges to NTD control remain.
There is a need to complete elimination efforts for schistosomiasis in
the Caribbean [74], and to eliminate the transmission of LF,
onchocerciasis, and trachoma in Latin America. Control or
elimination of the highest burden NTDs, e.g., Chagas disease,
STH infections, and hookworm and schistosomiasis co-infections,
still requires intensified efforts. Chagas disease remains one of the
region’s most devastating NTDs, and even in the southern cone
where domestic transmission has been nearly eliminated through
vector control of T. infestans, there are concerns about emerging
insecticide resistance [48], or the possibility that the vacant niches
will be eventually be occupied by other triatomine vectors [50]. In
the Chaco, elimination of T. infestans vectors has not been achieved
[48,49], while in Mexico, Central America, the northern tropical
regions of South America, and elsewhere, elimination efforts have
been thwarted by sylvatic T. dimidiata vectors, which can re-invade
dwellings following the use of insecticides [50]. For the case
management and treatment of both Chagas disease and leishman-
iasis, the major drugs used are either expensive or toxic or both, and
frequently require long periods of supervised therapy [50]. There is
an urgent need for developing safer anti-Chagas drug regimens and
more accurate diagnostic tools to assess the efficacy of anti-
trypanosomal drugs, particularly during the chronic phase of the
disease [48]. Hookworm infection and other STH infections remain
highly prevalent, especially in Brazil, where co-endemic hookworm
infection and schistosomiasis (and hookworm and schistosomiasis co-
infections) account for large-scale disability and lost economic
productivity [22,23,75,76]. Overall, the nation of Brazil accounts for
the highest NTD burden in the Americas, and even though Brazil is
also the largest country in LAC, its NTD burden is disproportion-
ately high [77]. In addition to high rates of hookworm and
schistosomiasis, Brazil also has the greatest number of cases of
leishmaniasis, leprosy, and leptospirosis [77]. Also of concern are the
five priority NTD-endemic countries, Bolivia, Guyana, Haiti,
Honduras, and Nicaragua, targeted by PAHO for accelerated
technical cooperation [8].
Approaches to Control or Elimination of the NTDs
in LAC
In sub-Saharan Africa an important approach to NTD control
relies on the concept of integration and the simultaneous targeting
of the most highly prevalent NTDs, i.e., ascariasis, trichuriasis,
hookworm infection, schistosomiasis, LF, onchocerciasis, and
trachoma, through MDA with a ‘‘rapid-impact’’ package of drugs
[1]. In most of LAC, however, the distribution of the NTDs is not
as widespread and therefore not always amenable to the same
African control strategies. With the exceptions of some areas of
eastern Brazil where STH and schistosome infections are also co-
endemic with LF (Pernambuco and Alagoas States), and in the
Amazonian basin where, particularly among indigenous people,
STH infections overlap with onchocerciasis and trachoma
(northern Brazil), there are limited opportunities to administer a
full rapid-impact package in the Americas. Instead, the pattern of
NTD endemicity in the most impoverished areas of LAC has a
unique regional character, typically with STH infections or
Chagas disease, the most widespread NTDs, co-endemic with a
few other NTDs, especially zoonotic NTDs.
As shown in Table 8, at least 11 different sub-regions with
unique human and environmental ecologies that promote NTDs
have been initially identified in LAC. The regional sociodemo-
graphic character of LAC’s NTDs include high prevalence in the
densely populated and forgotten urban slums and highly
concentrated pockets of intense rural poverty characterized by
poor or no access to basic services, such as safe water and
sanitation, electricity, schooling, and health care, where both
human-derived and environmental factors promote NTD trans-
mission. Equally important are the unique geographies of areas
such as the dry and cold Altiplano, the dry and barren Chaco, the
isolated Central America highlands, and parts of the Amazonian
and Caribbean basins, each representing NTD ‘‘hot spots’’ where
marginalized and often impoverished populations of indigenous
people or people of African descent live in great poverty. For
example, some indigenous communities in the Amazonian basin
suffer simultaneously from STH infections, onchocerciasis,
cutaneous leishmaniasis, scabies, tungiasis, and mycoses. Intense
human migrations in the region because of mining, urbanization,
deforestation, desertification, and armed conflict represent addi-
tional external factors that promote NTD transmission
[12,48,78,79].
All of these settings are characterized by poor housing and lack
of safe water and basic sanitation as co-factors of transmission.
Within such settings, all three major STH infections are nearly
ubiquitous among preschool and school-aged children, while
hookworm infection is also common in pregnant women. Co-
endemic with the STH infections are combinations of one or more
of the following NTD infections: schistosomiasis (particularly in
eastern Brazil), the vector-borne filarial diseases LF (Caribbean,
northeastern Brazil) and onchocerciasis (northern Pacific of South
America, Central America, and southern Mexico), leishmaniasis
(in all sub-regions except the Caribbean), and other zoonotic
NTDs. Similarly, in many of the poorest sub-regions, Chagas
disease remains highly endemic. Possibly, for more than any other
NTD, the knowledge gaps for Chagas disease remain the greatest,
particularly with respect to the extent of zoonotic transmission
from dogs and other animals, the emergence and re-emergence of
triatomine vectors, the role of bednets, and the lack of specific tools
for case management [48]. In addition, the extent of co-infections
with Chagas disease and the other major NTDs is not well
established. As summarized in Table 9, several different modalities
are required to control or eliminate the unique NTDs in these 11
sub-regions, including MDA, targeted administration together
with intensified early case detection and management, integrated
vector management, control of animal reservoirs, behavioral
interventions, and other specialized measures [8].
Countries in the LAC region are exploring different and novel
platforms for the integrated delivery of NTD health services, and
are synergizing NTD control with other disease control efforts and
programs. For example, supported by grants from USAID and the
Gates Foundation, Haiti is implementing a pilot project to
combine MDA for LF elimination and STH control, while the
Honduras Ministry of Health is piloting studies to add deworming
for STH control to its maternal and child health, vitamin A
delivery, and Chagas disease vector control programs. In the
Dominican Republic, the Ministry of Health has successfully
integrated MDA into its primary health care system in the
southwest region [80]. Similarly, in Nicaragua, deworming is
conducted in conjunction with annual nationwide child vaccina-
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www.plosntds.org 8 September 2008 | Volume 2 | Issue 9 | e300tion campaigns, and in Ecuador multiple partners collaborate to
implement deworming of families as a part of a nutritional
outreach program targeting the poorest communities. In Argen-
tina, Brazil, Peru, and other countries, in technical collaboration
with PAHO, Chagas disease integrated control programs now
include blood bank screening, residual insecticide treatment of
vector-infested homes, health promotion and education, and
community surveillance and reporting of house re-infestation [49],
with plans underway to add screening and treatment to prevent
congenital Chagas disease transmission. To date, these innovations
are relatively new, but it is expected that they will be adopted and
scaled in other LAC countries in the coming years.
Future Trends: The Inter-Sectoral Approach for
Sustainable NTD Control
In recognition of the severe NTD disease burden in the
Americas, the PAHO/WHO, together with the LAC govern-
ments, their national disease control programs, the US Centers for
Disease Control and Prevention, and the Global Network for
Neglected Tropical Diseases [1] will be embarking on efforts to
further control, or in some cases, eliminate the region’s NTDs. To
this end, a strategic plan is being developed, which will be
important to MDG targets for health and sustainable poverty
reduction in LAC by 2015 [81] (Table 10). The plan uses the
existing epidemiological data and adapts an ecosystems approach
(Tables 8 and 9) in order to define the most effective interventions
that will tackle the multifactoral determinants responsible for the
persistence of NTDs, placing health within the context of social
and economic development and key MDGs [72].
Rather than a strictly disease-centered approach [4,9,72,82],
comprehensive public policies aimed at community development
and poverty reduction will be adopted. These policies will be then
implemented at the local level through the mobilization and
involvement of various agencies [9,72] under the responsibility of
different government sectors (inter-sectoral action) so that they can
come together in a synergistic and synchronic manner. Together
with strong social participation and appropriate technologies, the
inter-sectoral action completes the three pillars advocated in a
primary health care strategy and will contribute towards health
systems strengthening. Examples of such inter-sectoral partnering
were recently reviewed [72,82]. The collateral benefits of NTD
control and elimination also provide multiple entry points for
linking diverse programs and projects within the health sector and
among different sectors [9,72,82], and could build on several
PAHO/WHO and World Bank initiatives to combat disease and
deprivation [8,9]. A new generation of control tools, including
vaccines, some under development by product development
partnerships that include research, development, and manufac-
turing institutions in LAC, would represent additional innovations
to fold into these infrastructures [83]. Among them are new drugs
and human vaccines for dengue, hookworm (and hookworm–
schistosomiasis co-infections), leishmaniasis, and leprosy
[76,84,85], as well as transmission-blocking interventions for
Chagas disease, cysticercosis, fascioliasis, leptospirosis, and leish-
maniasis, which target major animal reservoir hosts [48,84].
Overall, the control and/or elimination of NTDs represent a
highly cost-effective mechanism for providing new investment
opportunities in areas currently plagued with these diseases and
freeing up their economic potential, i.e., for tourism and
ecotourism, ecologically sound mining and oil exploration,
infrastructure for rural community transportation, and sustainable
crop production (traditional and non-traditional crops). The
treatment and prevention of the NTDs have also been revealed
as an ethical imperative to respond to the fundamental human
right to health [86], particularly for LAC’s poorest people, its
indigenous populations and people of African descent.
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